Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Translational Medicine
Published in: Journal of Translational Medicine 1/2005

Open Access 01-12-2005 | Commentary

The not-for-profit form and translational research: Kerr revisited?

Author: Keith A Joiner

Published in: Journal of Translational Medicine | Issue 1/2005

Login to get access

Abstract

Translational research conducted in academic health centers is confounded by the organizational structure in which the work is performed. Investigators must obtain research funding and appropriate recognition as a part of a research team in a not-for-profit environment which has more readily rewarded basic work, and individual accomplishments. What results is a unique form of conflict of interest, best understood by relating the basic principles underlying the not-for-profit form to the conduct of translational research in the AHC setting.
Literature
1.
Kerr S: An Academy Classic On the folly of rewarding A while hoping for B. Academy of Management Executive. 1995, 9:
2.
3.
Oster SM: Strategic Management for Nonprofit Organizations Theory and Cases. 1995, , Oxford University Press
4.
Hansmann HB: The role of nonprofit enterprise. The Yale Law Journal. 1980, 89: 835-898.CrossRef
5.
Unterman I, Davis R: Strategic Management of Not-For-Profit Organizations. 1984, New York,
6.
Salamon LM: America's Non-Profit Sector: A Primer. 1992, New York, The Foundation Center
7.
Ott JS: The Nature of the Nonprofit Sector. 2000, , Westview Press
8.
9.
Kotchen TA, Lindquist T, Malik K, Ehrenfeld E: NIH peer review of grant applications for clinical research. Jama. 2004, 291: 836-843. 10.1001/jama.291.7.836.CrossRefPubMed
10.
Williams GH, Wara DW, Carbone P: Funding for patient-oriented research. Critical strain on a fundamental linchpin. JAMA. 1997, 278: 227-231. 10.1001/jama.278.3.227.CrossRefPubMed
11.
Sung NS, Crowley WFJ, Genel M, Salber P, Sandy L, Sherwood LM, Johnson SB, Catanese V, Tilson H, Getz K, Larson EL, Scheinberg D, Reece EA, Slavkin H, Dobs A, Grebb J, Martinez RA, Korn A, Rimoin D: Central challenges facing the national clinical research enterprise. Jama. 2003, 289: 1278-1287. 10.1001/jama.289.10.1278.CrossRefPubMed
12.
Snyderman R: The clinical researcher--an "emerging" species. Jama. 2004, 291: 882-883. 10.1001/jama.291.7.882.CrossRefPubMed
13.
Crowley WFJ, Sherwood L, Salber P, Scheinberg D, Slavkin H, Tilson H, Reece EA, Catanese V, Johnson SB, Dobs A, Genel M, Korn A, Reame N, Bonow R, Grebb J, Rimoin D: Clinical research in the United States at a crossroads: proposal for a novel public-private partnership to establish a national clinical research enterprise. Jama. 2004, 291: 1120-1126. 10.1001/jama.291.9.1120.CrossRefPubMed
14.
Stokes DE: Pasteur's Quadrant: Basic Science and Technological Innovation. 1997, Washington, D.C., The Brookings Institution
15.
Gross CP, Anderson GF, Powe NR: The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med. 1999, 340: 1881-1887. 10.1056/NEJM199906173402406.CrossRefPubMed
16.
Varmus H: Evaluating the burden of disease and spending the research dollars of the National Institutes of Health. N Engl J Med. 1999, 340: 1914-1915. 10.1056/NEJM199906173402411.CrossRefPubMed
17.
IOM: Scientific opportunities and public needs: improving the priority setting and publich input at the National Institutes of Health. 1998, Washington, D.C., Institute of Medicine; National Academy Press
18.
Martin J: Research in biomedicine. Is anyone representing/advocating the public interest?. Eur J Public Health. 2001, 11: 458-459. 10.1093/eurpub/11.4.458.CrossRefPubMed
19.
Brown LP, Bair AH, Meier PP: Does federal funding for breastfeeding research target our national health objectives?. Pediatrics. 2003, 111: e360-4. 10.1542/peds.111.4.e360.CrossRefPubMed
20.
Levinsky NG: Nonfinancial conflicts of interest in research. N Engl J Med. 2002, 347: 759-761. 10.1056/NEJMsb020853.CrossRefPubMed
21.
von Schroeder HP: The altruistic medical researcher: gone and forgotten?. Ann R Coll Physicians Surg Can. 1997, 30: 353-358.PubMed
22.
Facilitating Interdisciplinary Research. Edited by: National Academy of Sciences NAEIM. 2005, Washington, D.C., National Academies Press
Metadata
Title
The not-for-profit form and translational research: Kerr revisited?
Author
Keith A Joiner
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2005
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-3-19

Other articles of this Issue 1/2005

Journal of Translational Medicine 1/2005 Go to the issue

Research

Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome

Review

Ovarian cancer, the coagulation pathway, and inflammation

Commentary

A balanced review of the status T cell-based therapy against cancer

Research

CD34+ cells cultured in stem cell factor and interleukin-2 generate CD56+ cells with antiproliferative effects on tumor cell lines

Research

Protein kinase activity is associated with CD63 in melanoma cells

Research

The subcellular distribution of myeloid-related protein 8 (MRP8) and MRP14 in human neutrophils
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits